In this episode of Digital Pathology Today, Visikol CEO Michael Johnson, PhD discusses 3D imaging in digital pathology. We look at the current and future uses of 3D imaging. We talk about the current state of the art in multiplexing particularly for clinical use. We discover more about organoids, what they are and how they will play a part in research and what Vsikol has in store for the future.
